The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment
奥法妥木单抗(一种全人源抗CD20单克隆抗体)的研发及其在复发型多发性硬化症治疗中的实际应用
期刊:Neurology and Therapy
影响因子:4.8
doi:10.1007/s40120-023-00518-0
Hauser, Stephen L; Kappos, Ludwig; Bar-Or, Amit; Wiendl, Heinz; Paling, David; Williams, Mitzi; Gold, Ralf; Chan, Andrew; Milo, Ron; Das Gupta, Ayan; Karlsson, Goeril; Sullivan, Roseanne; Graham, Gordon; Merschhemke, Martin; Häring, Dieter A; Vermersch, Patrick
单克隆抗体
神经科学
多发性硬化症
CD20
Human
CD2